SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-23-019036
Filing Date
2023-06-30
Accepted
2023-06-30 16:16:45
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 dmtp20230628_s3.htm S-3 485535
2 EXHIBIT 4.6 ex_539608.htm EX-4.6 93384
3 EXHIBIT 5.1 ex_539609.htm EX-5.1 10190
4 EXHIBIT 23.1 ex_539773.htm EX-23.1 2801
5 EXHIBIT FILING FEES ex_539610.htm EX-FILING FEES 19219
6 a01.jpg GRAPHIC 7066
7 c01.jpg GRAPHIC 53896
8 pm.jpg GRAPHIC 33528
  Complete submission text file 0001437749-23-019036.txt   742360
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-273068 | Film No.: 231061947
SIC: 2834 Pharmaceutical Preparations